CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SAGhE project investigates the long-term safety and effectiveness of growth hormone treatments in children. By analyzing a large cohort, it aims to assess the impact on height and potential cancer risks associated with these therapies.
Recombinant growth hormone (GH) has been used since 1985.
Current indications for GH use in children include GH deficiency and an increasing number of conditions where childhood short stature is not primarily due to deficient GH secretion.
Approximately 40 000 children in the EU are treated with daily injections of GH.
The efficacy of GH to increase adult height is undisputed in children with severe GH deficiency but is more limited in other indications where current estimates suggest a gain of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL
Belgium, Bruxelles / Brussel
Type: Other
Activity type: Other
SME: No
Germany, Leipzig
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Roma
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
